- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
Researchers confirm first case of COVID-19 reinfection in Hong Kong
![Researchers confirm first case of COVID-19 reinfection in Hong Kong Researchers confirm first case of COVID-19 reinfection in Hong Kong](https://medicaldialogues.in/h-upload/2020/06/23/750x450_130811-covid-19-and-diabetes.webp)
Hong Kong: The researchers have reported a first confirmed case of COVID-19 reinfection in Hong Kong. According to the case report which is yet to be published in the journal Clinical Infectious Diseases, a 33-year-old man in Hong Kong was diagnosed with COVID-19 on March 26, hospitalized, then recovered. Then again, he tested positive for SARS-CoV-2 again on August 15. The whole-genome sequencing obtained from viral isolates of the two episodes indicated them to be from different clade. Interestingly, during the second infection, the patient was asymptomatic.
During the March episode, the man had experienced fever and a deep, productive cough. He was discharged on April 14 following two negative SARS-CoV-2 tests, taken a day apart.
In August, when that man was returning to Hong Kong from Spain via the United Kingdom, he tested positive for SARS-CoV-2 on the reentry screening at the Hong Kong Airport. He remained asymptomatic and afebrile but was hospitalized. Lab abnormalities included slightly elevated CRP and hypokalemia. The patient's SARS-CoV-2 load fell during hospitalization, based on serial PCR testing.
Kwok-Yung Yuen, the University of Hong Kong, and colleagues' manuscript has been accepted for publication in the above-mentioned journal but is yet to be published.
Although there has been previous news of COVID-19 reinfection but such cases were never documented. As what appeared to be reappeared was simply prolonged infection according to many experts. But in this case, the researchers confirmed it to be a case of reinfection and not persistent viral shedding from the first infection, through epidemiological, clinical, serological and genomic analyses.
Whole genome sequencing found the first viral genome to be closely related to SARS-CoV-2 strains from the U.S. or England collected in March/April strain and the second viral genome was most closely related to strains from Switzerland and England in July/August. There were 24 nucleotide differences suggesting different strains.
Other evidence that researchers offered that it was indeed reinfection was relatively high viral load with gradual decline and elevated C-reactive protein in the patient. Also, there was long period of 142 days between infections considering that viral RNA is undetectable one month after symptom onset, and prolonged viral shedding has only ever been documented up to 104 days after infection.
"Our findings suggest that SARS-CoV-2 may persist in the global human population as is the case for other common-cold associated human coronaviruses, even if patients have acquired immunity via natural infection," the authors wrote in a press release.
MSc. Biotechnology
Medha Baranwal joined Medical Dialogues as an Editor in 2018 for Speciality Medical Dialogues. She covers several medical specialties including Cardiac Sciences, Dentistry, Diabetes and Endo, Diagnostics, ENT, Gastroenterology, Neurosciences, and Radiology. She has completed her Bachelors in Biomedical Sciences from DU and then pursued Masters in Biotechnology from Amity University. She has a working experience of 5 years in the field of medical research writing, scientific writing, content writing, and content management. She can be contacted at  editorial@medicaldialogues.in. Contact no. 011-43720751
Dr Kamal Kant Kohli-MBBS, DTCD- a chest specialist with more than 30 years of practice and a flair for writing clinical articles, Dr Kamal Kant Kohli joined Medical Dialogues as a Chief Editor of Medical News. Besides writing articles, as an editor, he proofreads and verifies all the medical content published on Medical Dialogues including those coming from journals, studies,medical conferences,guidelines etc. Email: editorial@medicaldialogues.in. Contact no. 011-43720751